Jun-ichirou Mori

465 total citations
21 papers, 379 citations indexed

About

Jun-ichirou Mori is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Jun-ichirou Mori has authored 21 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Genetics. Recurrent topics in Jun-ichirou Mori's work include Retinoids in leukemia and cellular processes (3 papers), Thyroid Disorders and Treatments (3 papers) and Virus-based gene therapy research (2 papers). Jun-ichirou Mori is often cited by papers focused on Retinoids in leukemia and cellular processes (3 papers), Thyroid Disorders and Treatments (3 papers) and Virus-based gene therapy research (2 papers). Jun-ichirou Mori collaborates with scholars based in Japan and United States. Jun-ichirou Mori's co-authors include Kiyoshi Hashizume, Satoru Suzuki, Kazuo Ichikawa, Teiji Takeda, Takahide Miyamoto, Aki Oshima, Shin‐ichi Usami, Nobuyoshi Suzuki, Akira Matsuo and Yoshitaka Kaneita and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Endocrinology and Molecular Endocrinology.

In The Last Decade

Jun-ichirou Mori

21 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jun-ichirou Mori Japan 12 124 117 66 58 40 21 379
Weimin Qu China 11 7 0.1× 140 1.2× 56 0.8× 134 2.3× 30 0.8× 15 672
Inmaculada Crespo Spain 12 16 0.1× 119 1.0× 16 0.2× 42 0.7× 47 1.2× 16 392
Tania Ferraro Australia 20 77 0.6× 225 1.9× 7 0.1× 33 0.6× 70 1.8× 25 1.4k
Chenyu Ye China 11 41 0.3× 176 1.5× 11 0.2× 3 0.1× 10 0.3× 22 447
Michael Beckert United States 13 138 1.1× 107 0.9× 9 0.1× 81 1.4× 61 1.5× 27 607
Gregory D. Stewart Australia 13 26 0.2× 347 3.0× 16 0.2× 28 0.5× 47 1.2× 32 702
Yifan Xu China 11 16 0.1× 109 0.9× 31 0.5× 43 0.7× 20 0.5× 44 397
Luisa Herrera Chile 14 40 0.3× 213 1.8× 10 0.2× 19 0.3× 190 4.8× 33 567
Ourania Kosti United States 10 29 0.2× 214 1.8× 43 0.7× 41 0.7× 27 0.7× 16 453
Behnaz Esmaeili United States 10 13 0.1× 60 0.5× 28 0.4× 94 1.6× 13 0.3× 21 336

Countries citing papers authored by Jun-ichirou Mori

Since Specialization
Citations

This map shows the geographic impact of Jun-ichirou Mori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun-ichirou Mori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun-ichirou Mori more than expected).

Fields of papers citing papers by Jun-ichirou Mori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun-ichirou Mori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun-ichirou Mori. The network helps show where Jun-ichirou Mori may publish in the future.

Co-authorship network of co-authors of Jun-ichirou Mori

This figure shows the co-authorship network connecting the top 25 collaborators of Jun-ichirou Mori. A scholar is included among the top collaborators of Jun-ichirou Mori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun-ichirou Mori. Jun-ichirou Mori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamashita, Koh, et al.. (2022). Reduction of Severe Hypoglycemic Events Among Outpatients with Type 2 Diabetes Following Sodium-Glucose Cotransporter 2 Inhibitor Marketing in Japan. Hormone and Metabolic Research. 54(11). 747–753. 1 indexed citations
2.
Munezawa, Takeshi, Yoshitaka Kaneita, Yoneatsu Osaki, et al.. (2010). Nightmare and sleep paralysis among Japanese adolescents: A nationwide representative survey. Sleep Medicine. 12(1). 56–64. 65 indexed citations
3.
Kaneita, Yoshitaka, Takeshi Munezawa, Hiroyuki Suzuki, et al.. (2010). Excessive daytime sleepiness and sleep behavior among Japanese adolescents: A nation-wide representative survey. Sleep and Biological Rhythms. 8(4). 282–294. 12 indexed citations
4.
Suzuki, Satoru, Jun-ichirou Mori, & Kiyoshi Hashizume. (2007). μ-crystallin, a NADPH-dependent T3-binding protein in cytosol. Trends in Endocrinology and Metabolism. 18(7). 286–289. 32 indexed citations
5.
Suzuki, Satoru, Nobuyoshi Suzuki, Jun-ichirou Mori, et al.. (2007). μ-Crystallin as an Intracellular 3,5,3′-Triiodothyronine Holder in Vivo. Molecular Endocrinology. 21(4). 885–894. 51 indexed citations
6.
Suzuki, Satoru, Jun-ichirou Mori, Masanori Yamazaki, et al.. (2007). Beneficial Effects of Pioglitazone on Cholangiohepatitis Induced by Bile Duct Carcinoma. Internal Medicine. 46(20). 1723–1728. 2 indexed citations
7.
Suzuki, Satoru, Jun-ichirou Mori, Masayuki Kobayashi, et al.. (2003). Cell-specific expression of NADPH-dependent cytosolic 3,5,3'-triiodo-L-thyronine-binding protein (p38CTBP). European Journal of Endocrinology. 148(2). 259–268. 16 indexed citations
8.
Suzuki, Shinichi, Jun-ichirou Mori, Masayuki Kobayashi, et al.. (2003). Presence of Functional Domains in NADPH-dependent Cytosolic 3,5,3'-Triiodo-L-thyronine (T3)-binding Protein (p38CTBP) Molecule: Analyses with Deletion Mutants. Hormone and Metabolic Research. 35(10). 577–582. 4 indexed citations
9.
Takeda, Teiji, Masanori Yamazaki, Satoru Suzuki, et al.. (2002). A tandemly repeated thyroglobulin core promoter has potential to enhance efficacy for tissue-specific gene therapy for thyroid carcinomas. Cancer Gene Therapy. 9(10). 864–874. 14 indexed citations
10.
Mori, Jun-ichirou, Satoru Suzuki, Mutsuhiro Kobayashi, et al.. (2002). Nicotinamide Adenine Dinucleotide Phosphate-Dependent Cytosolic T3 Binding Protein as a Regulator for T3-Mediated Transactivation. Endocrinology. 143(4). 1538–1544. 40 indexed citations
11.
12.
Ichikawa, Kazuo, Takahide Miyamoto, Tomoko Kakizawa, et al.. (2000). Mechanism of liver-selective thyromimetic activity of SK&F L-94901: evidence for the presence of a cell-type-specific nuclear iodothyronine transport process. Journal of Endocrinology. 165(2). 391–397. 15 indexed citations
13.
14.
Mori, Jun-ichirou, et al.. (2000). Cloning and characterization of a cDNA encoding serine palmitoyltransferase in Arabidopsis thaliana. Biochemical Society Transactions. 28(6). 745–745. 2 indexed citations
15.
Tamura, Kentaro, et al.. (2000). Cloning and characterization of a cDNA encoding serine palmitoyltransferase in Arabidopsis thaliana. Biochemical Society Transactions. 28(6). 745–747. 14 indexed citations
16.
Mori, Jun-ichirou, Satoru Suzuki, Masahiro Hara, et al.. (1999). Characterization of Two Novel Retinoic Acid‐resistant Cell Lines Derived from HL‐60 Cells Following Long‐term Culture with all‐trans‐Retinoic Acid. Japanese Journal of Cancer Research. 90(6). 660–668. 7 indexed citations
17.
Suzuki, Satoru, Masahiro Hara, Jun-ichirou Mori, et al.. (1999). 1,25-Dihydroxyvitamin D3Suppresses the Expression of the VCAM-1 Receptor, VLA-4 in Human Leukemic HL-60 Cells. Biochemical and Biophysical Research Communications. 255(2). 371–376. 8 indexed citations
18.
Horimi, Tadashi, Satoshi Morita, Isao Takeda, et al.. (1993). [Hormone therapy of tamoxifen in resected carcinoma of the pancreas].. PubMed. 94(7). 730–5. 6 indexed citations
19.
Mori, Jun-ichirou, et al.. (1990). Material design of monolithic refractories for steel ladle. American Ceramic Society bulletin. 69(7). 1172–1176. 46 indexed citations
20.
Mori, Jun-ichirou, et al.. (1973). SERUM LH DURING OVULATORY AND ANOVULATORY MENSTRUAL CYCLES IN MACAQUES. European Journal of Endocrinology. 73(4). 751–758. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Weimin Qu Breakdown of academic impact, for papers by Inmaculada Crespo Breakdown of academic impact, for papers by Tania Ferraro Breakdown of academic impact, for papers by Chenyu Ye Breakdown of academic impact, for papers by Michael Beckert Breakdown of academic impact, for papers by Gregory D. Stewart Breakdown of academic impact, for papers by Yifan Xu Breakdown of academic impact, for papers by Luisa Herrera Breakdown of academic impact, for papers by Ourania Kosti Breakdown of academic impact, for papers by Behnaz Esmaeili
Rankless by CCL
2026